BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 27, 2017
Clinical News

IMP321: Ph I TACTI-mel ongoing

BioCentury | Jan 13, 2017
Clinical News

IMP321: Interim Ph IIb AIPAC data

BioCentury | Jan 3, 2017
Clinical News

IMP321: Ph I TACTI-mel ongoing

BioCentury | Apr 18, 2016
Clinical News

IMP321: Phase I/IIa data

BioCentury | Mar 7, 2016
Clinical News

IMP321: Phase IIb started

BioCentury | Feb 1, 2016
Clinical News

IMP321: Phase I started

BioCentury | Oct 14, 2013
Company News

Eddingpharm, Immutep deal

BioCentury | Oct 5, 2009
Clinical News

ImmuFact IMP321: Phase I data

Items per page:
1 - 10 of 23